OrthoPediatrics to Participate in Upcoming Conferences

WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences.

Event: TD Cowen 46^th Annual Health Care Conference
Format: Fireside Chat
Date: Tuesday, March 3, 2026
Time: 1:10 pm ET

Event: The Citizens Life Sciences Conference
Format: Fireside Chat
Date: Tuesday, March 10, 2026
Time: 10:10 am ET

An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available for 90 days after the event.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
[email protected] 
415-937-5406

You May Also Be Interested In

• CZR Foundation Publishes $CZR Public Roadmap Through 2027 Ahead of October 1 Launch
• This Meme Coin Isn’t Just About Hype: Apeing Adds 85% APY, Referral Rewards, and Ape Wars as the Best Crypto to Buy Now
• Best Crypto To Buy Now: Pons Jumps 15% as AlphaPepe Gives Retail the Entry Before Its First Market Run